Direct Lobbying Transparency
| Overall Assessment | Comment | Score |
|---|---|---|
| Strong | Samsung Biologics provides a relatively detailed picture of its climate-policy lobbying. It identifies the main policy arenas it engages on, naming the “K-ETS” (the Korean Emissions Trading Scheme) and involvement in the “policy and law on net zero,” including the “2045 Incheon Metropolitan City Net Zero Strategy,” and situates these within the Republic of Korea carbon-pricing framework, showing transparency about specific policy instruments. The company sets out the ways it seeks to influence these policies, noting that it “communicates with government policymakers by participating in government-hosted public hearings and policy briefings related to greenhouse gas regulations,” engages in “discussions with government agencies regarding measures for additional allocation for the newly constructed Plant 4,” and works through an MOU with “Incheon Metropolitan City” and other local institutions—clearly describing multiple mechanisms and identifying its governmental targets. It also discloses the objectives of these efforts, stating that it aims to “adapt to forthcoming changes in emission allowance allocation, paid allocation, and emission calculation methods,” to “support the government in achieving their NDC goals,” and to contribute to the “2045 Incheon Metropolitan City Net Zero Strategy,” thereby clarifying the outcomes it seeks. Together, these elements demonstrate a strong level of transparency on the company’s climate-related lobbying activities. | 3 |